Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05288751 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Contingency Management for Opioid and Stimulant Use Disorders in Primary Care

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Aug 31, 2026 → Oct 31, 2026
See other at-risk trials from University of Minnesota

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 31, 2026 to Oct 31, 2026
    • Eligibility criteria expanded, about 6 words
  2. Primary and study completion dates: May 29, 2025 to Aug 31, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 42 to confirmed 56
    • Site details revised
    v9
  3. Trial status: Suspended to Recruiting
    • Primary completion date: Sep 29, 2023 to May 29, 2025
    • Site details revised
    v8
  4. Trial status: Active, Not Recruiting to Suspended Sponsor's reason: Funding
    • Primary completion date: Mar 29, 2023 to Sep 29, 2023
    • Study completion date: May 29, 2024 to May 29, 2025
    v7
  5. Study completion date: Oct 16, 2023 to May 29, 2024v6
Show 4 earlier versionsHide 4 earlier versions
  1. Enrollment target: estimated 200 to confirmed 42v5
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Sep 16, 2023 to Mar 29, 2023
    • Study completion date: Mar 16, 2024 to Oct 16, 2023
    • Site details revised
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 20, 2022 to Jun 15, 2022
    • Site details revised
    v3
  4. Start date: Mar 16, 2022 to Apr 20, 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Contingency management (CM) is a behavioral intervention that involves incentivizing participants for target behaviors in a clinical setting. When applied to the treatment of substance use disorders, it has demonstrated efficacy in reducing the number of urine toxicology screens positive for illicit substances and increased engagement in treatment programs. However, there is a need to translate CM treatment to primary care settings. This study will implement and assess a CM program for patients with opioid use disorder, with or without comorbid stimulant use disorder, initiating outpatient addiction medicine services at a family medicine residency clinic. Eligible patients will earn monetary incentives for attending addiction medicine appointments and abstaining from substances during outpatient treatment. Data gathered from this pilot program will be used to improve patient outcomes, treatment, and retention for persons receiving medications for opioid use disorder (MOUDs) in a primary care setting.
Trial Details
NCT Number NCT05288751
Lead Sponsor University of Minnesota
Conditions
(from sponsor)		 Opioid Use Disorder, Stimulant Use Disorder
Related terms Opioid-Related Disorders
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov